
Keywords: CPS; chemoprophylaxis with sporozoites; CQ; chloroquine; CQ-CPS; chloroquine chemoprophylaxis with sporozoites; DHA-PPQ; co-formulation of dihydroartemisinin and piperaquine-tetraphosphate; GMP; good manufacturing practice; PPQ; piperaquine-tetraphosphate